Brokerages Anticipate Meridian Bioscience, Inc. (VIVO) Will Post Quarterly Sales of $50.49 Million


Analysts expect that Meridian Bioscience, Inc. will announce $50.49 million in sales for the current fiscal quarter, according to Zacks . Two analysts have issued estimates for Meridian Bioscience's earnings.



from Biotech News